深圳市海王英特龙生物技术股份有限公司（08329）于2026年1月2日发布2025年12月股份变动月报。公告显示，截至12月31日，公司注册股本保持在人民币42,600,000元（对应普通股426,000,000股，每股面值人民币0.1元），无任何增减。
从已发行股份结构来看，H股426,000,000股及内资股1,252,000,000股均无新增发行、购回或注销，期末维持原有规模未变，总股本保持在1,678,000,000股。
公告同时披露，公司于报告期内无任何股份期权或股权激励计划的增减；亦无其他购回、注销及库存股份变动事项。公司确认遵守香港联交所上市规则及相关法律规定，股本总数整体保持稳定。
该月报由公司H股股份过户及登记处卓佳证券登记有限公司呈交并确认。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.